ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ¹é½Å À¯Çüº°, °¡¼öº°, Åõ¿© °æ·Îº°, ¿¬·ÉÃþº°, ±â¼úº°, À¯Åë ä³Îº°, Áö¿ªº°
Influenza Vaccines Market, By Vaccine Type, By Valency, By Route of Administration, By Age Group, By Technology, By Distribution Channel, By Geography
»óǰÄÚµå : 1672819
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀº 2025³â¿¡´Â 89¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 145¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 7.3%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 89¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) 7.30% ±Ý¾× ¿¹Ãø(2032³â) 145¾ï 9,000¸¸ ´Þ·¯
±×¸². ÀÎÇ÷翣ÀÚ ¹é½Å Áö¿ªº° ½ÃÀå Á¡À¯À²(%)(2025³â)
Influenza Vaccines Market-IMG1

ÀÎÇ÷翣ÀÚ ¹é½ÅÀº ¼ö½Ê³âµ¿¾È ¿¹¹æ ÀÇ·áÀÇ Áß¿äÇÑ ¿ä¼Ò°¡ µÇ¾ú½À´Ï´Ù. ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º´Â Á¤±âÀûÀ¸·Î º¯ÀÌ ¹× ÁøÈ­Çϱ⠶§¹®¿¡ ¸Å³â Ãֽйé½ÅÀ» °³¹ßÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. ¹é½ÅÀº º¯È­ÇÏ´Â ¹ÙÀÌ·¯½º¿¡ ´ëÇÑ ½ÅüÀÇ ¸é¿ª ¹ÝÀÀÀ» Çâ»ó½ÃŰ´Â ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ¹é½ÅÀº °¨½Ã ¹× ±âŸ °úÇÐÀû Á¶»ç¸¦ ÅëÇØ ¾î´À Áö¿ª¿¡¼­µµ ´ÙÀ½ ÀÎÇ÷翣ÀÚ ½ÃÁð¿¡ °¡Àå À¯ÇàÇÒ °ÍÀ¸·Î ÆÇ´ÜµÇ´Â 3-4ÁÖ(ƯÁ¤ ÀÎÇ÷翣ÀÚ ½ÃÁð¿¡ »ç¿ëµÇ´Â ¹é½Å À¯Çü¿¡ µû¶ó ´Ù¸§)¿¡ ´ëÇÑ ¸é¿ªÀ» °­È­Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀº °èÀý¼º ¹é½Å Á¢Á¾¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í, ½Å±â¼ú ä¿ë, ÀÇ·á±â°ü¿¡ ÀÇÇÑ ¹é½Å Á¢Á¾ °¡À̵å¶óÀÎ È®´ë, ¼¼°è Á¤ºÎ Áö¿øÀÇ °íÁ¶¿¡ ÀÇÇØ Áö³­ ¼ö³â°£ ¾ÈÁ¤µÈ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀåÀÇ ¼ºÀåÀº ÀÎÇ÷翣ÀÚÀÇ À¯Çà Áõ°¡, ±¹Á¦ º¸°Ç±â±¸°¡ Á¤ÇÑ ¹é½Å Á¢Á¾ °¡À̵å¶óÀΠä¿ë È®´ë, ¹é½Å Á¢Á¾¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶, ½ÅÁ¦Ç° Ãâ½Ã, ÀçÁ¶ÇÕ ±â¼ú ¹é½Å¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Áö¸®Àû ¹üÀ§ È®´ë µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ±×·¯³ª, 4°¡ ÀÎÇ÷翣ÀÚ ¹é½ÅÀÇ °³¹ß¿¡ µå´Â ³ôÀº ¿¬±¸°³¹ßºñ, ½Å¹é½ÅÀÇ ½ÂÀο¡ Àû¿ëµÇ´Â ¾ö°ÝÇÑ ±ÔÁ¦ °¡À̵å¶óÀÎ, ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½ºÁÖÀÇ Ç׿ø µå¸®ÇÁÆ®¿¡ ÀÇÇØ ¹é½Å ³»¼ºÀÌ »ý±â´Â °Í µîÀÌ ½ÃÀå ¼ºÀåÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå °ü°èÀÚ´Â ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÇ°í °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÏ´Â ½ÅÈï±¹¿¡ ºñÁî´Ï½º ±âȸ°¡ ÀÖ´Ù°í »ý°¢ÇÕ´Ï´Ù. Á¦Á¶¾÷ü´Â ¶ÇÇÑ ¿©·¯ ÀÎÇ÷翣ÀÚ ±ÕÁÖ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¹¹æ È¿°ú¸¦ Áö´Ñ ´ÙÀç´Ù´ÉÇÑ ¹é½ÅÀ» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ¹é½Å À¯Çüº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : °¡¼öº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : Åõ¿© °æ·Îº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ¿¬·ÉÃþº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦9Àå ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : ±â¼úº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦10Àå ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : À¯Åë ä³Îº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦11Àå ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å ½ÃÀå : Áö¿ªº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦12Àå °æÀï ±¸µµ

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ ½ÃÁ¡

Á¦14Àå Âü°í¹®Çå ¹× Á¶»ç¹æ¹ý

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Influenza Vaccines Market is estimated to be valued at USD 8.91 Bn in 2025 and is expected to reach USD 14.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.91 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.30% 2032 Value Projection: USD 14.59 Bn
Figure. Influenza Vaccines Market Share (%), By Region 2025
Influenza Vaccines Market - IMG1

Influenza vaccines have been an important element of preventive healthcare for decades. The influenza viruses have the ability to mutate and evolve regularly, necessitating the development of updated vaccines each year. The vaccines work to boost the body's immune response to these changing viruses. They are designed to immunize against the three or four strains (depending on the vaccine type used for a particular flu season) that surveillance and other scientific studies have determined are most likely to be in circulation for the upcoming flu season in any given region. The global influenza vaccines market has witnessed steady growth over the past few years due to the growing awareness about seasonal vaccination, introduction of novel technologies, expansion of vaccination guidelines by healthcare organizations, and rising government support worldwide.

Market Dynamics:

The global influenza vaccines market growth is driven by various factors such as the increasing prevalence of influenza, growing adoption of vaccination guidelines set by international health organizations, rising awareness about vaccination, new product launches, growing preference for recombinant technology vaccines, and expansion in geographical reach of major players. However, the market growth can be challenging due to high R&D costs involved for development of quadrivalent influenza vaccines, stringent regulatory guidelines for approval of new vaccines and vaccine resistance arising due to antigenic drift of influenza virus strains. The market players see opportunities in emerging countries owing to improving healthcare infrastructure and rising disposable incomes. Manufacturers are also working on the development of universal influenza vaccine with durable protection against multiple flu strains.

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Influenza Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

5. Global Influenza Vaccines Market, By Vaccine Type, 2020 - 2032, (USD BN)

6. Global Influenza Vaccines Market, By Valency, 2020 - 2032, (USD BN)

7. Global Influenza Vaccines Market, By Route of Administration, 2020 - 2032, (USD BN)

8. Global Influenza Vaccines Market, By Age Group, 2020 - 2032, (USD BN)

9. Global Influenza Vaccines Market, By Technology, 2020 - 2032, (USD BN)

10. Global Influenza Vaccines Market, By Distribution Channel, 2020 - 2032, (USD BN)

11. Global Influenza Vaccines Market, By Region, 2020 - 2032 (USD BN)

12. Competitive Landscape

13. Analyst View

14. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â